Log in

ISDE News

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 29 Dec 2020 4:21 PM | Anonymous


    Minimally invasive esophagectomy is a complex operation with a long learning curve and the robotic platform has allowed increased utilization of a minimally invasive approach. Outcomes data comparing robotic and open approaches show improved results with robotic assisted minimally invasive esophagectomy (RAMIE) in terms of perioperative morbidity and recovery yet preserving oncological outcomes.

    This special supplement published in the ISDE Diseases of the Esophagus Journal contains a comprehensive collection of articles about robotic esophagectomy written by leading surgeons around the world. It serves as a useful resource for surgeons wanting to improve their skills and for students and trainees that are approaching the field of surgery.

    Listen to Richard van Hillegersberg, University Medical Center Utrecht (The Netherlands) and Daniela Molena, Memorial Sloan Kettering Cancer Center (USA) talk about this Special Supplement on Robotic Assisted Minimally Invasive Esophagectomy: A New Standard of Care?


    OPEN DOTE Supplement on Robotic Assisted Esophagectomy


    ABOUT ISDE Diseases of the Esophagus Journal


  • 21 Dec 2020 3:48 PM | Anonymous

    Submitted by Mark K. Ferguson, MD

    This second edition of the well accepted first edition edited by Professor Ando contains up-to-date information on squamous esophageal cancer from a variety of perspectives.  Diagnosis, classification, staging, and Japanese guidelines are detailed.  Chapters on endoscopic therapy, surgery, and multimodality therapy offer the latest views.  Finally, chapters from other Asian perspectives are provided, including India, China, Hong Kong, and Korea.  This book is recommended as a comprehensive guide to diagnosis and management.

    Find out more about the Esophageal Squamous Cell Carcinoma book online.

  • 18 Dec 2020 3:04 PM | Anonymous

    Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are heartburn and regurgitation, but other clinical presentations can be present.

    The Controversies in Gastroesophageal Reflux Disease virtual presentation was held on December 16, 2020. Moderated by Jan Tack, University of Leuven (The Netherlands) and Kerry Dunbar, University of Texas Southwestern Medical Center (USA) the 90 minute presentation is available in three segments below. What different segments when you have time or all at once, the choice is yours.

    Part 1 | Long term PPI therapy with Kerry Dunbar


    Part 2 | Endoscopic management of GERD with Haruhiro Inoue


    Part 3 | When to consider surgery with John Lipham

    ISDE wishes to recognize and thank the following individuals for their contributions to this virtual presentation:

    • Jan Tack, University of Leuven (The Netherlands)
    • Kerry Dunbar, University of Texas Southwestern Medical Center (USA) (moderator and speaker)
    • Haruhiro Inoue, Showa University School of Medicine (Japan)
    • John Lipham, Keck School of Medicine of USC (USA)

    Want to know more?

    WATCH Interviews and Discussions in the GERD Playlist

    Search Diseases of the Esophagus Journal for articles on Gastroesophageal Reflux Disease. There are 55 Free articles available.

    Join the discussion in the ISDE Challenging Cases Facebook Group


  • 14 Dec 2020 8:33 PM | ISDE Office (Administrator)

    As we approach the end of 2020, and look forward to a new year, I think we can all agree that this year has been unlike any other. In January, we started hearing reports from China about a new respiratory disease, and saw it rapidly impact Wuhan, and then escalate to a lock-down in China, before escalating to impact international travel. As I flew from Australia to Hawaii in early February, travel from China to many parts of the world was closing, and when I returned home 2 weeks later the situation was moving fast. We have all now seen national borders close and international travel severely disrupted, and this ultimately impacted our ability to travel to Toronto for the ISDE’s 2020 Congress. I am also aware that I haven’t left my own Australian State since February, and even though Australia has been less affected than Europe and the Americas, it has still been through “lock-downs” and we are yet to return to a situation that resembles what we previously took for granted. Even though mass vaccines now seem to be just over the horizon, it is likely we will continue to experience travel restrictions and need to continue with public health measures for a further 12 months.

    To respond to the challenges of this environment, and then thrive, ISDE has rapidly adjusted what it does and how it operates. I have been impressed by how well the Society has pivoted to Zoom, and also by the enthusiasm and support from many members from around the World who are serving the membership by developing and leading online education and other activities. ISDE’s webinars are delivering education and keeping us in contact with our friends and peers. These webinars have delivered content pertinent to the impact of COVID on the management of esophageal disease, a virtual tumour board, and the best of the best free papers submitted for our delayed 2020 congress. Online events have greatly expanded the reach of ISDE, and they will continue across the coming year and beyond. If you have ideas for more, or want to get more involved, please let us know.

    As I look towards the next 12 months, I am confident that there is much that the ISDE can still accomplish. The COVID world has opened up new opportunities for engagement, and the ISDE has a unique opportunity to enhance its offerings to members, to grow membership, and further cement itself as the peak international organisation for esophageal disease. As President, my hope is that we can build on the opportunities that 2021 will bring, engage even more effectively with the membership despite the limitations imposed by the global pandemic, and that the ISDE will emerge as a stronger and more effective organisation in the post-pandemic world.

    As we approach the end of the year, I hope all of the ISDE members around the world have an opportunity to rest and catch their breath – after 2020 we all need to! For many of you this is a holiday season – Happy Holidays! Happy New Year! For some of you there is some more significance at this time – Merry Christmas!

  • 30 Nov 2020 4:44 PM | ISDE Office (Administrator)

    It's time to renew your ISDE membership. On December 2 members will receive a renewal email reminder containing renewal instructions. If you do not receive this email please check your Junk/Spam folder, or contact membership@isde.net.

  • 30 Nov 2020 4:43 PM | ISDE Office (Administrator)

    Join the ISDE Challenging Cases Facebook group discussions on GERD after sleeve gastrectomy, Management of esophageal atresia, Giant hernia and Esophageal lymphoma.

    Would you like to share an interesting case with this Facebook group anonymously? Submit it to membership@isde.net and we will post it for you.

  • 30 Nov 2020 4:42 PM | ISDE Office (Administrator)

    Presentation date: 16 December 2020 at 13:30- 15:00 GMT

    Join us for the last virtual presentation this year on Controversies in Gastroesophageal Reflux Disease featuring an international panel discussing long term PPI therapy, endoscopic management of GERD and when to consider surgery. Moderators Jan Tack (University of Leuven, The Neverlands) and Kerry Dunbar (University of Texas Southwestern Medical, USA) will be joined by Haruhiro Inoue (Showa University, Japan) and John Lipham (Keck School of Medicine, USA) for this live event. REGISTER FOR FREE.

  • 30 Nov 2020 4:40 PM | ISDE Office (Administrator)

    The Diseases of the Esophagus Journal is pleased to present this 2nd Supplement developed by guest editors Richard van Hillegersberg MD, PhD* and Daniela Molena, MD.

    Robotic equipment: what do we need for a robotic-assisted minimally invasive esophagectomy (RAMIE)?

    DOTE Volume 33, Issue Supplement 2| Featured Article

    Members Only Article

    Surgical resection is the cornerstone for local control and long-term survival of patients with locally advanced esophageal cancer treated by multimodality therapy. The evolution of minimally invasive esophagectomy (MIE) to include telerobotics has contributed to expanding the capabilities of performing this complex operation through minimally invasive techniques. Robotic surgery enhances several key aspects of minimally invasive surgery, such as enhanced vision, stable view, and highest precision due to articulated instrumentation and scaling of motion.1 Sign in to read the full Robotic equipment article.
  • 30 Nov 2020 4:38 PM | ISDE Office (Administrator)

    Checkout the latest DOTE issue for articles on Benign Esophageal and Malignant Esophageal Diseases; See the full table of contents.

    Review a collection of the top ten articles from recent years in a reading list.

    Meta-analysis of prognostic factors of overall survival in patients undergoing oesophagectomy for oesophageal cancer

    DOTE Volume 33, Issue 11 | Editor's Choice

    Free Article

    Currently, the American Joint Commission on Cancer (AJCC) staging system is used for prognostication for oesophageal cancer. However, several prognostically important factors have been reported but not incorporated. This meta-analysis aimed to characterize the impact of preoperative, operative, and oncological factors on the prognosis of patients undergoing curative resection for oesophageal cancer. Read the full Meta-analysis of prognostic factors article for free.

    Prevalence and clinical significance of esophageal abnormalities in children with celiac disease

    DOTE Volume 33, Issue 11 | Editor's Choice

    Free Article

    Variable endoscopic and histological findings of esophageal lining are often detected in celiac disease, with unknown significance. We investigated the frequency and significance of such abnormalities in children. Macroscopic esophageal findings as reported by endoscopist and histological results by pathologist were compared between 316 celiac disease patients and 378 disease controls who had undergone upper gastrointestinal endoscopy with systematic esophageal biopsy sampling. Read the full Prevalence and clinical significance article for free.

    Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma

    DOTE Volume 33, Issue 11 | Featured Article

    Members Only Article

    Both cervical (McKeown) and intrathoracic (Ivor Lewis) anastomosis of transthoracic esophagectomy are surgical procedures that can be performed for distal esophageal or gastro-esophageal junction (GEJ) cancer. The purpose of this study was to investigate the long-term health-related quality of life (HR-QoL) after McKeown and Ivor Lewis esophagectomy in a tertiary referral center. Read the full Long-term health-relatedtic factors article.

  • 20 Nov 2020 2:48 PM | Anonymous

    Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett’s Esophagus for development of precancerous change (dysplasia).

    The Multidisciplinary Approaches to Early Barrett’s Cancer virtual presentation was held on November 18, 2020. Moderated by Sheila Krishnadath, Amsterdam University Medical Center (The Netherlands) and Prateek Sharma, University of Kansas (USA) the 90 minute presentation is available in four segments below. Watch different segments when you have time or all at once, the choice is yours.

    Part 1 | Advanced Endoscopic Imaging for Diagnosing with Prateek Sharma


    Part 2 | Endoscopic Resection (Japanese Perspective) with Seiichiro Abe


    Part 3 | Role of Surgery with George Hanna


    Part 4 | Surveillance and Follow-up with Kenneth Wang


    ISDE wishes to recognize and thank the following individuals for their contributions to this virtual presentation:

    • Sheila Krishnadath, Amsterdam University Medical Center (Netherlands)
    • Prateek Sharma, University of Kansas Medical Center (USA)
    • Seiichiro Abe, National Cancer Center Hospital (Japan)
    • George Hanna, Imperial College (UK)
    • Kenneth Wang, Mayo Clinic Rochester (USA)

    Want to know more?

    WATCH Interviews & Discussions on Barrett’s Esophagus

    See Research and Guidelines on Barrett’s Esophagus

    Search Diseases of the Esophagus Journal for articles on Barrett’s Esophagus. There are 36 Free Editor’s Choice articles available.

    Join the discussion in the ISDE Challenging Cases Facebook Group.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software